Viviopia,
If only 15 patients out of 48 progress, that is amazing.
But from the information given we don't know if that's the case.
There are a number of reasons why they might only limit the study to 15.
2b trial variation-safety profile assessment, page-10
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $501.1M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 34.8¢ | 33.5¢ | $198.3K | 578.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 70769 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 335387 | 16 |
View Market Depth
| Last trade - 14.08pm 29/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |